Our population‐based cohort study links VOCs‐expanded LYM to elevated obstructive lung disease risk, with exposed individuals showing higher IL‐6 and IL‐17A levels (Figure S10, Supporting Information). The gene discussed is IL17A; the disease is Airway obstruction.